1. Home
  2. SNOA vs SYRA Comparison

SNOA vs SYRA Comparison

Compare SNOA & SYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNOA
  • SYRA
  • Stock Information
  • Founded
  • SNOA 1999
  • SYRA 2020
  • Country
  • SNOA United States
  • SYRA United States
  • Employees
  • SNOA N/A
  • SYRA N/A
  • Industry
  • SNOA Biotechnology: Pharmaceutical Preparations
  • SYRA Other Specialty Stores
  • Sector
  • SNOA Health Care
  • SYRA Industrials
  • Exchange
  • SNOA Nasdaq
  • SYRA Nasdaq
  • Market Cap
  • SNOA 4.6M
  • SYRA 4.2M
  • IPO Year
  • SNOA 2007
  • SYRA 2023
  • Fundamental
  • Price
  • SNOA $2.56
  • SYRA $0.36
  • Analyst Decision
  • SNOA
  • SYRA
  • Analyst Count
  • SNOA 0
  • SYRA 0
  • Target Price
  • SNOA N/A
  • SYRA N/A
  • AVG Volume (30 Days)
  • SNOA 97.7K
  • SYRA 178.3K
  • Earning Date
  • SNOA 11-07-2024
  • SYRA 10-29-2024
  • Dividend Yield
  • SNOA N/A
  • SYRA N/A
  • EPS Growth
  • SNOA N/A
  • SYRA N/A
  • EPS
  • SNOA N/A
  • SYRA N/A
  • Revenue
  • SNOA $13,547,000.00
  • SYRA $7,741,558.00
  • Revenue This Year
  • SNOA $36.00
  • SYRA $47.74
  • Revenue Next Year
  • SNOA $25.26
  • SYRA N/A
  • P/E Ratio
  • SNOA N/A
  • SYRA N/A
  • Revenue Growth
  • SNOA 11.81
  • SYRA 35.47
  • 52 Week Low
  • SNOA $2.52
  • SYRA $0.34
  • 52 Week High
  • SNOA $9.40
  • SYRA $8.37
  • Technical
  • Relative Strength Index (RSI)
  • SNOA 39.95
  • SYRA 33.92
  • Support Level
  • SNOA $2.76
  • SYRA $0.37
  • Resistance Level
  • SNOA $2.84
  • SYRA $0.44
  • Average True Range (ATR)
  • SNOA 0.21
  • SYRA 0.04
  • MACD
  • SNOA -0.01
  • SYRA 0.00
  • Stochastic Oscillator
  • SNOA 0.01
  • SYRA 3.27

About SNOA Sonoma Pharmaceuticals Inc.

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.

About SYRA Syra Health Corp.

Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.

Share on Social Networks: